Acinetobacter baumannii has become a major concern for scientific attention due to
extensive antimicrobial resistance. This resistance causes an increase in mortality rate …

Acinetobacter baumannii is a nosocomial pathogen that has emerged as a global threat
because of high levels of resistance to many antibiotics, particularly those considered to be …

Carbapenem-resistant Acinetobacter baumannii (CRAB) has become one of the leading
causes of healthcare-associated infections globally, particularly in intensive care units …

INTRODUCTION: The increase in the prevalence of multidrug-resistant Acinetobacter
baumannii infections in hospital settings has rapidly emerged worldwide as a serious health …

Background Acinetobacter baumannii has emerged as one of the common multidrug
resistance pathogens causing hospital-acquired infections. This study was conducted to …

Carbapenem-resistant Acinetobacter baumannii (CRAB) is an important opportunistic
pathogen linked to a variety of nosocomial infections and hospital outbreaks worldwide. This …

INTRODUCTION Carbapenem-resistant Acinetobacter baumannii is a complex health
problem, causing difficulties in clinical–therapeutic management worldwide. It is of particular …

Introduction The aminoglycosides are widely used for the therapeutic management of
infections caused by gram-negative bacteria, including the Acinetobacter baumannii strains …

Abstract Objectives To characterize Acinetobacter baumannii strains co-producing the ESBL
CTX-M-115 and carbapenem-hydrolysing class D β-lactamases (CHDLs), and to assess the …

Bloodstream infection (BSI) caused by Acinetobacter baumannii poses a serious threat to
health and is correlated with high mortality in patients with hospital-acquired infections, so …